| http://www.w3.org/ns/prov#value | - The pharmaceutical said the lawsuits are a significant expansion of the Anti-Kickback Statute that is inconsistent with law and policy in this area, and by doing so the government will undermine pharmaceutical company discounting practices that benefit both consumers and payers, including the Government.
|
